Deal is at US$221.63m.
In a release, the boards of directors of Fosun Pharma and Fosun International announced that as at 27 May 2013 (Israeli local time), Sisram Medical acquired 95.20% equity interest in Alma Lasers for a total consideration of US$221.63 million.
Alma Lasersis a global medical technology company that designs, develops, manufactures and markets medical and cosmetic, energy-based devices.
As at 27 May 2013 (Israeli local time), Ample Up, CML and Pramerica-Fosun Fund (through its wholly-owned subsidiary, Magnificent View Investments Limited have contributed US$44.42 million, US$53.50 million and US$50.00 million, respectively to Sisram Medical.
Upon completion, Sisram Medical is owned as to 30.03%, 36.17% and 33.80% by Ample Up, CML and Magnificent View, respectively.
Do you know more about this story? Contact us anonymously through this link.